Lanutan, Charles C.

HRN: 23-58-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
AMPICILLIN 500MG (VIAL)
08/22/2023
08/29/2023
IV
410mg
Q4
PCAP C; BFC
Waiting Final Action 
08/22/2023
MUPIROCIN 2%, 15G (TUBE)
08/23/2023
08/30/2023
TOPICAL
15g
BID
Dermatitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: